Related Experiment Videos
Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to
1Department of Food Engineering and Biotechnology, Technion, Haifa, Israel.
The Journal of Biological Chemistry
|December 15, 1992
Summary
Human interferon consensus sequence binding protein (H-ICSBP) acts as a negative regulator of interferon-inducible genes in hematopoietic cells. Interferon treatment alleviates this repression, allowing for maximal gene activity.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- Interferon-inducible genes possess a shared DNA motif, the interferon consensus sequence (ICS).
- Several regulatory proteins bind to the ICS, influencing gene expression.
- A murine ICS binding protein (M-ICSBP) has been previously identified.
Purpose of the Study:
- To clone and characterize the human homologue of ICSBP (H-ICSBP).
- To investigate the DNA binding domain and regulatory function of H-ICSBP.
- To elucidate the role of H-ICSBP in interferon-inducible gene regulation in hematopoietic cells.
Main Methods:
- Cloning of the human ICSBP (H-ICSBP) cDNA.
- Sequence homology analysis comparing H-ICSBP to known interferon regulatory factors.
- Site-directed mutagenesis to identify the DNA binding domain.
- Transient transfection assays in hematopoietic and non-hematopoietic cells.
Main Results:
- H-ICSBP shares high sequence homology with M-ICSBP.
- The N-terminal 33 amino acids of H-ICSBP are crucial for ICS DNA binding.
- H-ICSBP is expressed exclusively in hematopoietic cell lines.
- H-ICSBP functions as a negative regulator of ICS-containing promoters.
- Interferon-gamma and Interferon-beta treatment can overcome H-ICSBP-mediated repression.
Conclusions:
- H-ICSBP is a novel interferon regulatory factor predominantly expressed in hematopoietic cells.
- H-ICSBP negatively regulates interferon-inducible genes by binding to the ICS.
- Interferon signaling alleviates H-ICSBP-mediated repression, enabling maximal gene transcription in response to interferons.